Documentation Centre

 

 

  of 828 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Closing the remaining evidence gap: Randomized controlled trial data to support statin therapy for low-density lipoprotein ≥190 mg/dL. Circulation. 2017;136:1892-1894 February 21, 2018 Closing the remaining evidence gap: Randomized controlled trial data to support statin therapy for low-density lipoprotein ≥190 mg/dL. Circulation. 2017;136:1892-1894 Watson KE, Fonarow GC Key Publications
Cardiovascular health, simplified. J Am Coll Cardiol. 2017;70:2474-2475 February 21, 2018 Cardiovascular health, simplified. J Am Coll Cardiol. 2017;70:2474-2475 Blumenthal RS, Ambinder DI, McEvoy JW Key Publications
Low-density lipoprotein cholesterol lowering for the primary prevention of cardiovascular disease among men with primary elevations of low-density lipoprotein cholesterol levels of 190 mg/dL or above: Analyses from the WOSCOPS (West of Scotland Coronary Prevention Study) 5-year randomized trial and 20-year observational follow-up. Circulation. 2017;136:1878-1891 February 20, 2018 Low-density lipoprotein cholesterol lowering for the primary prevention of cardiovascular disease among men with primary elevations of low-density lipoprotein cholesterol levels of 190 mg/dL or above: Analyses from the WOSCOPS (West of Scotland Coronary Prevention Study) 5-year randomized trial and 20-year observational follow-up. Circulation. 2017;136:1878-1891 Vallejo-Vaz AJ, Robertson M, Catapano AL, Watts GF, Kastelein JJ, Packard CJ, Ford I, Ray KK Key Publications
Inflammation and atherosclerosis: The end of a controversy. Circulation. 2017;136:1875-1877 February 20, 2018 Inflammation and atherosclerosis: The end of a controversy. Circulation. 2017;136:1875-1877 Hansson GK Key Publications
Predicting subclinical atherosclerosis in low-risk individuals: Ideal cardiovascular health score and Fuster-BEWAT score. J Am Coll Cardiol. 2017;70:2463-2473 February 20, 2018 Predicting subclinical atherosclerosis in low-risk individuals: Ideal cardiovascular health score and Fuster-BEWAT score. J Am Coll Cardiol. 2017;70:2463-2473 Fernández-Alvira JM, Fuster V, Pocock S, Sanz J, Fernández-Friera L, Laclaustra M, Fernández-Jiménez R, Mendiguren J, Fernández-Ortiz A, Ibáñez B, Bueno H Key Publications
Non-alcoholic fatty liver disease and impaired proinsulin conversion as newly identified predictors of the long-term non-response to a lifestyle intervention for diabetes prevention: results from the TULIP study. Diabetologia. 2017;60:2341-2351 February 15, 2018 Non-alcoholic fatty liver disease and impaired proinsulin conversion as newly identified predictors of the long-term non-response to a lifestyle intervention for diabetes prevention: results from the TULIP study. Diabetologia. 2017;60:2341-2351 Schmid V, Wagner R, Sailer C, Fritsche L, Kantartzis K, Peter A, Heni M, Häring HU, Stefan N, Fritsche A Key Publications
Not performing an OGTT results in significant underdiagnosis of (pre)diabetes in a high risk adult Caucasian population. Int J Obes (Lond). 2017;41:1615-1620 February 14, 2018 Not performing an OGTT results in significant underdiagnosis of (pre)diabetes in a high risk adult Caucasian population. Int J Obes (Lond). 2017;41:1615-1620 Meijnikman AS, De Block CEM, Dirinck E, Verrijken A, Mertens I, Corthouts B, Van Gaal LF Key Publications
Fruits, vegetables, and legumes: sound prevention tools. Lancet. 2017;390:2017-2018 February 13, 2018 Fruits, vegetables, and legumes: sound prevention tools. Lancet. 2017;390:2017-2018 Toledo E, Martínez-González MA Key Publications
Effect of diets rich in either saturated fat or n-6 polyunsaturated fatty acids and supplemented with long-chain n-3 polyunsaturated fatty acids on plasma lipoprotein profiles. Eur J Clin Nutr. 2017;71:1297-1302 February 13, 2018 Effect of diets rich in either saturated fat or n-6 polyunsaturated fatty acids and supplemented with long-chain n-3 polyunsaturated fatty acids on plasma lipoprotein profiles. Eur J Clin Nutr. 2017;71:1297-1302 Dias CB, Amigo N, Wood LG, Correig X, Garg ML Key Publications
Could you talk about the deleterious impacts of intra-abdominal or visceral obesity? February 09, 2018 Could you talk about the deleterious impacts of intra-abdominal or visceral obesity? Jean-Pierre Després, PhD, FAHA, FIAS, Scientific Director, ICCR, Professor, Division of Kinesiology, Université Laval, Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, QC, Canada Expert Opinions
Video 2:15 min.
(12 MB)

  of 828 Next page

Go to page: of